Autoantibodies in childhood opsoclonus-myoclonus syndrome

被引:29
|
作者
Blaes, F. [1 ]
Pike, M. G. [3 ]
Lang, B. [2 ]
机构
[1] Univ Giessen, Dept Neurol, Giessen, Germany
[2] Univ Oxford, Dept Clin Neurol, Oxford, England
[3] John Radcliffe Hosp, Dept Paediat Neurol, Oxford OX3 9DS, England
关键词
Opsoclonus-myoclonus syndrome; Dancing Eye Syndrome; Neuroblastoma; Autoantibodies; Cell proliferation; Case report;
D O I
10.1016/j.jneuroim.2008.05.033
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Opsoclonus-myoclonus syndrome or Dancing Eye Syndrome (OMS/DES) is a rare neurological disorder of children, which associates with neuroblastoma (NB) in approximately 50% of cases. We examined sera from five patients with (OMS-NB+) and five without NB (OMS-NB-) for autoantibodies. OMS-NB- IgG bound to the surface of a NB cell line, whereas IgG from OMS-NB+ and from NB patients Without OMS/DES bound only to permeabilised. cells. Both OMS-NB+ and OMS-NB- reduced proliferation of NB cells. We also present a case report of a child with OMS/DES without NB who made a complete recovery without treatment. Serum antibodies at presentation bound to the surface and decreased NB cell proliferation but had decreased 9 weeks later when the child was asymptomatic. These results demonstrate that sera from some OMS/DES patients contain IgG antibodies that are potentially pathogenic. (c) 2008 Elsevier B.V All rights reserved.
引用
收藏
页码:221 / 226
页数:6
相关论文
共 50 条
  • [21] Paraneoplastic opsoclonus-myoclonus syndrome with anti-neuronal cytoplasmic autoantibodies
    Jen, JC
    Lopez, I
    Charles, A
    DiPatre, PL
    Liu, F
    Sicotte, N
    Cloughesy, T
    Baloh, RW
    NEUROLOGY, 1998, 50 (04) : A12 - A12
  • [22] A case report of opsoclonus-myoclonus syndrome
    Krommyda, M.
    Rudolf, J.
    Deretzi, G.
    Mastrokosta, A.
    Kiourtidis, D.
    Tsiptsios, D.
    Tsironis, T.
    Ameridis, E.
    Tsiptsios, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 686 - 686
  • [23] Opsoclonus-myoclonus syndrome associated with leptospirosis
    Benmansour, Y.
    Manaf, S.
    El Moutawakil, B.
    Rafai, M. A.
    Slassi, I.
    REVUE NEUROLOGIQUE, 2013, 169 (6-7) : 523 - 524
  • [24] CHLORMETHIAZOLE IN THE MANAGEMENT OF THE OPSOCLONUS-MYOCLONUS SYNDROME
    VILCHEZ, JJ
    LAGO, A
    BURGUERA, JA
    YAYA, R
    CASANOVA, V
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1994, 22 (01) : 55 - 62
  • [25] Autoantigen diversity in the opsoclonus-myoclonus syndrome
    Bataller, L
    Rosenfeld, MR
    Graus, F
    Vilchez, JJ
    Cheung, NKV
    Dalmau, J
    ANNALS OF NEUROLOGY, 2003, 53 (03) : 347 - 353
  • [26] Paraneoplastic opsoclonus-myoclonus syndrome and neurofibrosarcoma
    Mitoma, H
    Orimo, S
    Sodeyama, N
    Tamaki, M
    EUROPEAN NEUROLOGY, 1996, 36 (05) : 322 - 322
  • [27] Opsoclonus-myoclonus syndrome: A case report
    Jomir, L.
    Sirvain, S.
    Bouly, S.
    Garrido, J. -F.
    Halle, O.
    REVUE DE MEDECINE INTERNE, 2009, 30 (11): : 980 - 981
  • [28] Ganglioneuroblastoma, intermixed with opsoclonus-myoclonus syndrome
    Kuyama, Hisako
    Nii, Akira
    Takehara, Hiroo
    Inoue, Nami
    Watanabe, Hiroyoshi
    Sakaki, Mika
    PEDIATRICS INTERNATIONAL, 2012, 54 (03) : e26 - e28
  • [29] Opsoclonus-myoclonus syndrome during pregnancy
    Koide, R
    Sakamoto, M
    Tanaka, K
    Hayashi, H
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2004, 24 (03) : 273 - 273
  • [30] A case of poststreptococcal opsoclonus-myoclonus syndrome
    Dassan, Pooja
    Clarke, Charles
    Sharp, David J.
    MOVEMENT DISORDERS, 2007, 22 (10) : 1490 - 1491